Respiratory Syncytial Virus Infections
8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Infections, Virus Diseases
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| abrysvo for respiratory syncytial virus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| abrysvo + Beyfortus for respiratory syncytial virus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Beyfortus for respiratory syncytial virus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for respiratory syncytial virus infections | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Nirsevimab for respiratory syncytial virus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| RSVPreF3 OA investigational vaccine for respiratory syncytial virus infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| S-337395 for respiratory syncytial virus infections | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Zelicapavir for respiratory syncytial virus infections | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.